Access to Health

Domestic Health─Achieve universal access to quality affordable health care

Since the Affordable Care Act went into effect in 2013, ICCR & NWCRI members have focused on ensuring its implementation among employers, medical device and pharmaceutical manufacturers, and insurance companies. Our goal is to increase the number of people that have health insurance and to bend the “cost curve” for health care so that it is more affordable.

Global Health─Advocate for access to health as a human right and the responsibility of pharmaceutical companies to increase access to medicines and services in vulnerable communities.

An important tool for our global health work is the 2016 Access to Medicine Index. This resource ranks 20 pharmaceutical companies on how they promote universal access to essential medicines to people living in the 107 countries with low or medium levels of development. While significant milestones for improving access to medicine have been achieved, there is still no sustainable model for ensuring that the poorest people have access to the medicines they need.

NWCRI leads the dialogues with Merck and Gilead Sciences, which rank fifth and eighth respectively in the Index.

Good News for Children Living with HIV
The Medicines Patent Pool (MPP) was established in 2010 with the goal of increasing access to HIV/AIDS medicines through the sharing of licenses by major pharmaceutical companies with generic manufacturers. Gilead Sciences was the only member until 2013. Now HIV/AIDS licensing agreements have been made with Bristol-Myers Squibb, Roche, AbbVie, Merck and ViiV Healthcare. The licenses from the latter four companies are for HIV/AIDs medicines for children in low- and middle-income countries where 99% of children with HIV live.

 

Resources on Access to Health